Section Arrow
Quote
SCNI.NASDAQ
- Scinai Immunotherapeutics Ltd.
(Financial Status)
Quotes are at least 15-min delayed:2026/06/21 20:21 EDT
Regular Hours
Last
 0.3215
-0.0155 (-4.60%)
Day High 
0.3429 
Prev. Close
0.337 
1-M High
0.5798 
Volume 
273.39K 
Bid
0.318
Ask
0.33
Day Low
0.31 
Open
0.333 
1-M Low
0.3001 
Market Cap 
1.74M 
Currency 美元 
P/E 0.18 
%Yield -- 
10-SMA 0.36 
20-SMA 0.42 
50-SMA 0.52 
52-W High 3.48 
52-W Low 0.3001 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.75/-0.81
Enterprise Value
3.68M
Balance Sheet
Book Value Per Share
1.19
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.31M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ADTXAditxt Inc.0.01+0.0056+127.27%-- 
CDTCDT Equity Inc.1.02+0.327+47.19%-- 
AZTRAzitra0.1717-0.0313-15.42%-- 
CRVOCervoMed4.24+0.43+11.29%-- 
OCGNOcugen1.24+0.01+0.81%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.